Clinical Trials List
Protocol NumberV503-002
2009-09-30 - 2021-10-18
Phase III
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chun-yi Lu Division of Pediatrics
- YING-CHENG CHIANG Division of Pediatrics
- 李冠霖 Division of Pediatrics
- 林筱琪 Division of Pediatrics
- 賴貞吟 Division of Pediatrics
- - - Division of Pediatrics
- 楊德亮 Division of Pediatrics
- 陳婉真 Division of Pediatrics
- Luan-Yin Chang Division of Pediatrics
- MEI-JOU CHEN Division of Pediatrics
- 李杰明 Division of Pediatrics
- 陳立倫 Division of Pediatrics
- 蔡幸真 Division of Pediatrics
- 戴君芙 Division of Pediatrics
- 邢子芸 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ting-Chang Chang Division of Obstetrics & Gynecology
- Yhu-Chering Huang Division of Pediatrics
- Angel Chao Division of Obstetrics & Gynecology
- 謝育嘉 Division of Pediatrics
- Tzou-Yien Lin Division of Pediatrics
- Ming-Li Hsieh Division of Urology
- 郭貞孍 Division of Pediatrics
- Huei-Jean Huang Division of Obstetrics & Gynecology
- Chi-Long Chen Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 楊順成 Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
150 participants
-
Global
2400 participants
